Med-Emerg International Inc. reports 39% revenue increase in third quarter



    TORONTO, Nov. 14 /CNW/ - Med-Emerg International Inc. (OTCBB - MDER)
reported today that revenues from continuing operations for the three months
ended September 30, 2007 increased 39% compared to the corresponding period in
2006. The increase in revenue reflects the growth of the Company's Medical
Services business, where the Pain Management and Infusion Services business
increased revenues 122% and 57%, respectively. For the three months ended
September 30, 2007, the Company incurred a loss from continuing operations of
($155,073) compared to a loss of $(187,869) in the corresponding period in
2006. The loss reflects the continued investment in the Company's Pain
Management business. While revenues in Pain Management grew, the Company
incurred certain costs to launch a new pain centre, along with the costs
associated with the internal infrastructure necessary to support the continued
growth of the Pain business.
    The loss attributable to common shareholders for the third quarter of
2007 was ($212,282) or ($0.004 per share), compared to income of $357,455 or
$0.005 per share, in same period of 2006. The income in the third quarter of
2006 was related to the settlement of a lawsuit in the period. Included in the
loss in the third quarter of 2007, is a loss from discontinued operations of
($57,209), resulting from losses at its Family Medical Clinic operations.
Effective July 31, 2007, the Company sold one of its two remaining Family
Medical Clinics.

    The Company's financial statement information for the three and nine
months ended September 30, 2007 is summarized below:

    
    (US$000's except share      Three Months Ended       Nine Months Ended
      information)                  Sept 30                  Sept 30
                             -----------------------  -----------------------
                                   2007        2006         2007        2006

    Revenue                       5,757       4,130       16,181      13,171
    EBITDA                          (33)       (132)        (225)        184
    Loss from continuing
     operations                    (155)       (188)        (514)        (62)
    Income (loss) from
     discontinued operations        (57)        545         (179)      1,181
    Net income (loss)
     attributable to common
     shareholders                  (212)        357         (693)      1,119

    Net income (loss) per
     common share (basis and
     diluted)
      Continuing operations      (0.003)     (0.003)      (0.009)     (0.001)
      Discontinued operations    (0.001)      0.009       (0.003)      0.020
    Weighted average shares
     outstanding, basic      58,277,696  58,277,696   58,277,696  58,277,696



    (US$000's)
                                                       September    December
    Balance Sheet Data:                                 30, 2007    31, 2006
      Working Capital Surplus                              2,671       3,912
      Total Assets                                         7,839       7,901
      Long-term debt                                         300         453
      Shareholders' equity - Canadian GAAP                   878       1,424
      Shareholders' equity -  US GAAP                        759         907
    

    MedEmerg specializes in the coordination and delivery of health care
services in Canada. These services include community-based infusion centers,
an integrated chronic pain management program, healthcare consulting, and
health human resource management, including physician and nurse staffing.

    All statements included in this press release that are not statements of
historical fact are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. The words "plan", "expect",
"believe", "intend", "anticipate", "forecast", "target", "estimate" and
similar expressions identify forward-looking statements. Forward-looking
statements are based on assumptions made by and information currently
available to the Company. Investors are cautioned that these forward-looking
statements are neither promises nor guarantees, and are subject to risks and
uncertainties that may cause future results to differ materially from those
expected. These risks and uncertainties are outlined in the Company's Annual
Report on Form 10-K for 2006, its Quarterly Reports on Form 10-Q, and such
other documents as are filed with the Securities and Exchange Commission from
time to time. The Company does not undertake to review or update these
forward-looking statements. The Company qualifies all of the information
contained in this press release, and particularly its forward-looking
statements, by these cautionary statements.

    %SEDAR: 00014075E




For further information:

For further information: Ramesh Zacharias, CEO, Med-Emerg International
Inc., Tel: (905) 858-1368, Email: rzacharias@med-emerg.com

Organization Profile

MED-EMERG INTERNATIONAL INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890